Monoclonal B‐cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B‐cell subsets

Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets.Little is known about the distribution of normal lymphoid cells and their subsets in the peripheral blood (PB) of subjects with monoclonal B-cell lymphocytosis (MBL). In our study, we compared the absolute number of PB lymphoid cells and their subpopulations in 95 MBL cases with normal lymphocyte counts vs. 617 age-/sex-matched non-MBL healthy subjects (controls), using highly sensitive flow cytometry. MBL cases showed significantly reduced numbers of normal circulating B-cells, at the expense of immature and naive B-cells; in addition, CD4+CD8+ double-positive T-cells and CD8+ T-cells were significantly lower and higher vs. controls, respectively. Moreover, most normal B-cell subsets were significantly decreased in PB at >1% MBL-counts, vs. "low-count" MBL cases, and lower amounts of immature/naive B-cells were detected in biclonal (particularly in cases with coexisting CLL-like- and non-CLL-like B-cell clones) vs. monoclonal MBL subjects. In summary, our results show imbalanced (reduced) absolute numbers of recently produced normal circulating B-cells (e.g., immature and naıve B-cells) in MBL, which becomes more pronounced as the MBL cell count increases.

[1]  P. Musto,et al.  Monoclonal B-Cell Lymphocytosis , 2014, Translational medicine @ UniSa.

[2]  Y. Mowery,et al.  Clinical aspects of monoclonal B-cell lymphocytosis. , 2012, Cancer control : journal of the Moffitt Cancer Center.

[3]  L. Pecciarini,et al.  General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. , 2011, Blood.

[4]  S. Deaglio,et al.  Circulating Regulatory T Cells in “Clinical” Monoclonal B-Cell Lymphocytosis , 2011, International journal of immunopathology and pharmacology.

[5]  C. E. Pedreira,et al.  CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults , 2011, Leukemia.

[6]  Bernard Klein,et al.  Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138− and CD138+ plasma cells , 2010, Haematologica.

[7]  T. Shanafelt,et al.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management , 2010, Leukemia.

[8]  A Orfao,et al.  Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic , 2010, Cytometry. Part B, Clinical cytometry.

[9]  A. Órfão,et al.  Non‐CLL‐like monoclonal B‐cell lymphocytosis in the general population: Prevalence and phenotypic/genetic characteristics , 2010, Cytometry. Part B, Clinical cytometry.

[10]  G. Marti,et al.  Prevalence of monoclonal B‐cell lymphocytosis: A systematic review , 2010, Cytometry. Part B, Clinical cytometry.

[11]  Neil E Caporaso,et al.  B-cell clones as early markers for chronic lymphocytic leukemia. , 2009, The New England journal of medicine.

[12]  Deborah A. Bowen,et al.  Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Marcos González,et al.  Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. , 2009, Blood.

[14]  D. Rossi,et al.  The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors , 2009, British journal of haematology.

[15]  L. Johnston,et al.  Competitive Interactions Between Cells: Death, Growth, and Geography , 2009, Science.

[16]  S. Richards,et al.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. , 2008, The New England journal of medicine.

[17]  Michael Hallek,et al.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.

[18]  Deborah A. Bowen,et al.  Prognostic importance of T and NK‐cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia , 2008, British journal of haematology.

[19]  G. Marti,et al.  Monoclonal B‐cell lymphocytosis as a biomarker in environmental health studies , 2007, British journal of haematology.

[20]  A. Rawstron,et al.  The biological and clinical relationship between CD5+23+ monoclonal B‐cell lymphocytosis and chronic lymphocytic leukaemia , 2007, British journal of haematology.

[21]  Mario Roederer,et al.  Quality assurance for polychromatic flow cytometry , 2006, Nature Protocols.

[22]  Paolo Ghia,et al.  Diagnostic criteria for monoclonal B‐cell lymphocytosis , 2005, British journal of haematology.

[23]  P. Aló,et al.  Homing of CD4+CD56+ T lymphocytes into kidney allografts during tubular necrosis or rejection. , 1995, Clinical Transplantation.

[24]  S. Tarui,et al.  T-cell abnormalities in patients with idiopathic thrombocytopenic purpura: the presence of OKT4+8+ cells. , 2009, Scandinavian journal of haematology.